Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

KDMN - Kadmon Holdings Inc

Close
9.5
0.020   0.211%

Share volume: 0
Last Updated: Mon 08 Nov 2021 10:00:01 PM CET
Pharmaceutical Preparation Manufacturing : -2.88%

PREVIOUS CLOSE
CHG
CHG%
$9.48
0.02
0.21%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
31%
Profitability 25%
Dept financing 45%
Liquidity 68%
Performance 25%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$9.50
P/E Ratio 
0.00
DAY RANGE
$9.48 - $9.50
EPS 
-$0.71
52 WEEK RANGE
$0.00 - $0.00
52 WEEK CHANGE
$0.00
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
178.521 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$0
AVERAGE 30 VOLUME 
$0
Company detail
CEO:
Region: US
Website: kadmon.com
Employees: 127
IPO year: -
Issue type: Common Stock
Market: NASDAQ
Industry: Pharmaceutical Preparation Manufacturing
Sector: Manufacturing

Kadmon is a clinical-stage biopharmaceutical company that discovers, develops and delivers transformative therapies for unmet medical needs. Its clinical pipeline includes treatments for immune and fibrotic diseases as well as immuno-oncology therapies.

Recent news